Does simian virus 40 cause non-Hodgkin lymphoma? A review of the laboratory and epidemiological evidence

Cancer Investigation

Volumn 23, Issue 6, 2005, Pages 529-536

  Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Non Hodgkin lymphoma; Poliovirus vaccines; Simian virus 40; SV40 antibody

Indexed keywords

INACTIVATED VACCINE; POLIOMYELITIS VACCINE; VIRUS ANTIBODY; VIRUS DNA; VIRUS VACCINE;

CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG CONTAMINATION; HUMAN; LYMPHOMA; NONHODGKIN LYMPHOMA; NONHUMAN; POLIOMYELITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEROPREVALENCE; SIMIAN VIRUS 40; VACCINATION; VIRUS DETECTION;

ANIMALS; HUMANS; LYMPHOMA, NON-HODGKIN; POLIOVIRUS VACCINES; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

EID: 26844459787     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900500202820     Document Type: Review

References (40)

1. Scherr, P.A.; Mueller, N.E. Non-Hodgkin's lymphomas. In Cancer Epidemiology and Prevention, 2nd Ed.; Schottenfeld, D., Fraumeni, J.F., Jr., Eds.; Oxford University Press: New York, 1996; 920-945.
2. Rizzo, P.; Carbone, M.; Fisher, S.G.; et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest 1999, 116, 470S-473S.
3. Shivapurkar, N.; Harada, K.; Reddy, J.; et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002, 359, 851-852.
4. Vilchez, R.A.; Madden, C.R.; Kozinetz, C.A.; et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002, 359, 817-823.
5. David, H.; Mendoza, S.; Konishi, T.; Miller, C.W. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett. 2001, 162, 57-64.
6. Martini, F.; Dolcetti, R.; Gloghini, A.; et al. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int. J. Cancer 1998, 78, 669-674.
7. Nakatsuka, S.; Liu, A.; Dong, Z.; Osaka Lymphoma Study Group; et al. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res. 2003, 63, 7606-7608.
8. Diamandopoulos, G.T. Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 1972, 176, 173-175.
9. Shah, K.V. Polyoma viruses (JC virus, BK virus, and simian virus 40) and human cancer. In Infectious Causes of Cancer: Targets for Intervention; Goedert, J.J., Ed.; Humana: Totowa, NJ, 2000; 461-474.
10. Shaikh, S.; Skoczylas, C.; Longnecker, R.; Rundell, K. Inability of simian virus 40 to establish productive infection of lymphoblastic cell lines. J. Virol. 2004, 78, 4917-4920.
11. Capello, D.; Rossi, D.; Gaudino, G.; Carbone, A.; Gaidano, G. Simian virus 40 infection in lymphoproliferative disorders. Lancet 2003, 361, 88-89.
12. MacKenzie, J.; Wilson, K.S.; Perry, J.; Gallagher, A.; Jarrett, R.F. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J. Natl. Cancer Inst. 2003, 95, 1001-1003.
13. Shah, K.; Nathanson, N. Human exposure to SV40: review and comment. Am. J. Epidemiol. 1976, 103, 1-12.
14. Immunization Safety Review. SV40 Contamination of Polio Vaccine and Cancer; National Academy Press: Washington, DC, 2003.
15. Völter, C.; zur Hausen, H.; Alber, D.; de Villiers, E.M. A broad spectrum PCR method for the detection of polyomaviruses and avoidance of contamination by cloning vectors. Dev. Biol. Stand. 1998, 94, 137-142.
16. Cole, C.N.; Conzen, S.D. Polyomaviridae: the viruses and their replication. In Fields Virology, 4th Ed.; Knipe, D.M., Howley, P.M., Eds.; Lippincott, Williams, and Wilkins: Philadelphia, 2001; 2141-2174.
17. Fredericks, D.N.; Relman, D.A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 1996, 9, 18-33.
18. Lopez-Rios, F.; Illei, P.B.; Rusch, V.; Ladanyi, M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 2004, 364, 1157-1166.
19. Brousset, P.; de Araujo, V.; Gascoyne, R.D. Immunohistochemical investigation of SV40 large T antigen in Hodgkin and non-Hodgkin's lymphoma. Int. J. Cancer 2004, 112, 533-535.
20. Engels, E.A.; Katki, H.A.; Nielsen, N.M.; et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J. Natl. Cancer Inst. 2003, 95, 532-539.
21. Gerber, P.; Hottle, G.A.; Grubbs, R.E. Inactivation of vacuolating virus (SV40) by formaldehyde. Proc. Soc. Exp. Biol. Med. 1961, 108, 205-209.
22. Carroll-Pankhurst, C.; Engels, E.A.; Strickler, H.D.; et al. Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period. Br. J. Cancer 2001, 85, 1295-1297.
23. Engels, E.A.; Rodman, L.H.; Frisch, M.; Goedert, J.J.; Biggar, R.J. Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma. Int. J. Cancer 2003, 106, 283-287.
24. Girardi, A.J.; Sweet, B.H.; Hilleman, M.R. Factors influencing tumor induction in hamsters by vacuolating virus, SV40. Proc. Soc. Exp. Biol. Med. 1963, 112, 662-667.
25. Strickler, H.D.; Rosenberg, P.S.; Devesa, S.S.; Hertel, J.; Fraumeni, J.F., Jr.; Goedert, J.J. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998, 279, 292-295.
26. Engels, E.A.; Chen, J.; Viscidi, R.P.; et al. Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer. Am. J. Epidemiol. 2004, 160, 306-316.
27. Strickler, H.D.; Goedert, J.J.; Devesa, S.S.; et al. Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J. Natl. Cancer Inst. 2003, 95, 38-45.
28. Communicable Disease Center. Poliomyelitis Surveillance Report No. 248; 1961, United States Department of Health, Education, and Welfare. Public Health Service, Atlanta.
29. Shah, K.V.; Daniel, R.W.; Strickler, H.D.; Goedert, J.J. Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J. Infect. Dis. 1997, 176, 1618-1621.
30. Bofill-Mas, S.; Pina, S.; Girones, R. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl. Environ. Microbiol. 2000, 66, 238-245.
31. Shah, K.V.; Galloway, D.A.; Knowles, W.A.; Viscidi, R.P. Simian virus 40 (SV40) and human cancer: a review of the serological data. Rev. Med. Virol. 2004, 14, 231-239.
32. Black, P.H.; Rowe, W.P.; Turner, H.C.; Huebner, R.J. A specific complement-fixing antigen present in SV40 tumor and transformed cells. Proc. Natl. Acad. Sci. 1963, 50, 1148-1156.
33. de Sanjose, S.; Shah, K.V.; Domingo-Domenech, E.; et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int. J. Cancer 2003, 104, 522-524.
34. Viscidi, R.P.; Rollison, D.E.M.; Viscidi, E.; et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin. Diagn. Lab. Immunol. 2003, 10, 278-285.
35. Engels, E.A.; Viscidi, R.P.; Galloway, D.A.; et al. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J. Natl. Cancer Inst. 2004, 96, 1368-1374.
36. Carter, J.J.; Madeleine, M.M.; Wipf, G.C.; et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J. Natl. Cancer Inst. 2003, 95, 1522-1530.
37. Rollison, D.E.M.; Helzlsouer, K.J.; Alberg, A.J.; et al. Serum antibodies to JC virus, BK virus, and simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol. Biomark. Prev. 2003, 12, 460-463.
38. Strickler, H.D.; Goedert, J.J.; Fleming, M.; et al. Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol. Biomark. Prev. 1996, 5, 473-475.
39. Hill, A.B. The environment and disease: association or causation? Proc. R. Soc. Med. 1965, 58, 295-300.
40. Strickler, H.D.; International SV40 Working Group. A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epidemiol. Biomark. Prev. 2001, 10, 523-532.